FI92069B - Förfarande för framställning av nya farmaceutiskt aktiva 1H-3H-pyrrolo/1,2-c/tiazol-7-karboxamidderivat - Google Patents

Förfarande för framställning av nya farmaceutiskt aktiva 1H-3H-pyrrolo/1,2-c/tiazol-7-karboxamidderivat Download PDF

Info

Publication number
FI92069B
FI92069B FI901325A FI901325A FI92069B FI 92069 B FI92069 B FI 92069B FI 901325 A FI901325 A FI 901325A FI 901325 A FI901325 A FI 901325A FI 92069 B FI92069 B FI 92069B
Authority
FI
Finland
Prior art keywords
mixture
solution
phenyl
mmhg
kpa
Prior art date
Application number
FI901325A
Other languages
English (en)
Finnish (fi)
Other versions
FI901325A0 (sv
FI92069C (sv
Inventor
Claude James
Daniel Lave
Francoise Soler
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of FI901325A0 publication Critical patent/FI901325A0/sv
Publication of FI92069B publication Critical patent/FI92069B/sv
Application granted granted Critical
Publication of FI92069C publication Critical patent/FI92069C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI901325A 1989-03-17 1990-03-16 Förfarande för framställning av nya farmaceutiskt aktiva 1H-3H-pyrrolo/1,2-c/tiazol-7-karboxamidderivat FI92069C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8903510A FR2644456B1 (fr) 1989-03-17 1989-03-17 Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent
FR8903510 1989-03-17

Publications (3)

Publication Number Publication Date
FI901325A0 FI901325A0 (sv) 1990-03-16
FI92069B true FI92069B (sv) 1994-06-15
FI92069C FI92069C (sv) 1994-09-26

Family

ID=9379793

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901325A FI92069C (sv) 1989-03-17 1990-03-16 Förfarande för framställning av nya farmaceutiskt aktiva 1H-3H-pyrrolo/1,2-c/tiazol-7-karboxamidderivat

Country Status (24)

Country Link
US (1) US5086051A (sv)
EP (1) EP0388309B1 (sv)
JP (1) JPH02289586A (sv)
KR (1) KR900014408A (sv)
AT (1) ATE102210T1 (sv)
BG (1) BG51159A3 (sv)
CA (1) CA2012343A1 (sv)
CS (2) CS276785B6 (sv)
DD (1) DD297822A5 (sv)
DE (1) DE69006872T2 (sv)
DK (1) DK0388309T3 (sv)
ES (1) ES2062432T3 (sv)
FI (1) FI92069C (sv)
FR (1) FR2644456B1 (sv)
IE (1) IE63313B1 (sv)
IL (1) IL93760A (sv)
MA (1) MA21771A1 (sv)
MX (1) MX26542A (sv)
NO (1) NO172392C (sv)
NZ (1) NZ232960A (sv)
PL (1) PL284321A1 (sv)
PT (1) PT93485B (sv)
TN (1) TNSN90030A1 (sv)
ZA (1) ZA902033B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW214545B (sv) * 1992-02-17 1993-10-11 Ciba Geigy Ag
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5463083A (en) 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
ES2152952T3 (es) 1992-07-13 2001-02-16 Millennium Pharm Inc 2,5-diaril tetrahidro-tiofenos, -furanos y analogos para el tratamiento de problemas inflamatorios e inmunes.
TW266206B (sv) * 1993-04-28 1995-12-21 Takeda Pharm Industry Co Ltd
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
DE69701298T2 (de) * 1996-04-15 2000-10-05 Takeda Chemical Industries Ltd Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung
US20080266643A1 (en) * 2005-08-19 2008-10-30 National Institute Of Advanced Industrial Science And Technology Electrode for Reversible Color Change Display Device and Method of Producing the Same, and Reversible Color Change Display Device and Reversible Color Change Lighting Control Device
WO2009125434A2 (en) * 2008-04-07 2009-10-15 Cadila Healthcare Limited Oxime derivatives
WO2014192023A1 (en) * 2013-05-22 2014-12-04 Cadila Healthcare Limited Novel compounds suitable for the treatment of dyslipidemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541280B1 (fr) * 1983-01-13 1985-06-21 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent
FR2601015B1 (fr) * 1986-07-04 1988-08-05 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CS125290A3 (en) 1992-03-18
NO172392C (no) 1993-07-14
TNSN90030A1 (fr) 1991-03-05
EP0388309A3 (fr) 1991-07-24
CS276785B6 (en) 1992-08-12
EP0388309B1 (fr) 1994-03-02
ES2062432T3 (es) 1994-12-16
IE63313B1 (en) 1995-04-05
NO901237L (no) 1990-09-18
NO172392B (no) 1993-04-05
DD297822A5 (de) 1992-01-23
PT93485A (pt) 1990-11-07
MX26542A (es) 1993-09-01
IL93760A0 (en) 1990-12-23
CS438990A3 (en) 1992-03-18
KR900014408A (ko) 1990-10-23
DE69006872D1 (de) 1994-04-07
US5086051A (en) 1992-02-04
EP0388309A2 (fr) 1990-09-19
IE900984L (en) 1990-09-17
FI901325A0 (sv) 1990-03-16
PT93485B (pt) 1996-02-29
ATE102210T1 (de) 1994-03-15
FR2644456B1 (fr) 1991-07-05
MA21771A1 (fr) 1990-10-01
ZA902033B (en) 1990-12-28
BG51159A3 (en) 1993-02-15
FR2644456A1 (fr) 1990-09-21
NO901237D0 (no) 1990-03-16
DK0388309T3 (da) 1994-04-11
JPH02289586A (ja) 1990-11-29
PL284321A1 (en) 1991-07-29
CA2012343A1 (fr) 1990-09-17
FI92069C (sv) 1994-09-26
NZ232960A (en) 1991-02-26
IL93760A (en) 1994-08-26
DE69006872T2 (de) 1994-06-30

Similar Documents

Publication Publication Date Title
FI92069B (sv) Förfarande för framställning av nya farmaceutiskt aktiva 1H-3H-pyrrolo/1,2-c/tiazol-7-karboxamidderivat
EP1493743B1 (en) Substituted bipiperidine intermediates and derivatives thereof
EP0465254B1 (en) Fused thiophene compounds and uses thereof
FI94343C (sv) Förfarande för framställning av terapeutiskt aktiva cykliska aminderivat
FI96690C (sv) Förfarande för framställning av en terapeutisk aktiv bensopyridopiperidin-, -piperidyliden- och -piperazinförening
CA1317292C (en) Derivatives of (1-hydroxy-2-piperidylalkyl)-indol-2-ones, 2-quinolinones, 2-benzo[b]azapinones, benzimidazol-2-ones, and quinazolin-2-ones, their preparation and their applicationin therapeutics
KR0167782B1 (ko) 테트라히드로피리딘 유도체
JPS59219260A (ja) 新規なナフタレン−およびアザナフタレン−カルボキサミド誘導体、それを含有する製薬学的組成物、並びにそれらの製造法
DE3522579C2 (de) Neue 1,4-Dihydropyridin-Derivate und Salze derselben, Verfahren zur Herstellung derselben und pharmazeutische Mittel mit einem Gehalt derselben
US4497808A (en) N-Oxide compounds useful in the treatment of cardiovascular ailments
FI89915B (fi) Foerfarande foer framstaellning av psykotropiska acykliska amidderivat
EP0009655B1 (en) 6-amino substituted n-pyrrolyl-3-pyridazine amines, their preparation, and pharmaceutically antihypertensive compositions containing them
Loza-Mejía et al. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure–activity relationship of 9-anilinothiazolo [5, 4-b] quinoline derivatives
CN108586378B (zh) 吲哚胺2,3-双加氧化酶抑制剂及其制备方法和用途
CA2501901A1 (en) Anticancer compounds
CH654001A5 (de) Benzothiazolin-verbindungen.
Baggaley et al. Inhibitors of blood platelet aggregation. Effects of some 1, 2-benzisothiazol-3-ones on platelet responsiveness to adenosine diphosphate and collagen
AT394560B (de) Sulfonylderivate der thieno-triazolo-diazepine, verfahren zu deren herstellung und sie enthaltendetherapeutische zusammensetzungen
HUT54151A (en) Process fopr producing new (r)-(-)-3-quinuclidinone derivatives and pharmaceutical compositions comprising such compounds
EP0596125A1 (en) Condensed thiophene compound and pharmaceutical use thereof
RO108347B1 (ro) DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
JPS62153280A (ja) １，４−ジアザシクロアルカン誘導体
EP0000716B1 (en) Pyrrolo(2,1-b)(3)benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them
BG98439A (bg) Кватернерни амониеви производни на (-) и (+) 10-(1-азобицикло /2.2.2/окт-3-ил-метил)-10н-фенотиазин,фармацевтични състави на тяхна основа и метод заполучаването им
JPS584020B2 (ja) シンキナイソキノリンルイ

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: RHONE-POULENC SANTE